Skip to record
ExecutivesErin Parsons

Executive record

Erin Parsons

Director at KIORA PHARMACEUTICALS INC

Follow record
More
Challenge a Claim

Alpha ID: alpha:person:erin-parsonsVersion: public-0As of: 2026-10-03

Not yet claimed7 published Claims3 sources
  • Director

Leadership, in context.

Connect capital, control, accountability, and evidence.

Published Claims7Within this recordEvidence sources3Inspect provenance and dates

Explore the record

ResponsibilitiesInspect board appointments and committee mandates.ExperienceReview career history and qualifications in context.Economic interestsExamine disclosed incentives and ownership.

Key Claims

Biography

Ms. Parsons is a Director since February 2022. She founded Parsons Medical Communications, LLC in 2010, providing scientific and strategic consulting to ophthalmic companies, serving as Managing Director and President until September 2022 when it was acquired by Fingerpaint Group. She served on the board of Alimera Sciences from December 2021 until its acquisition by ANI Pharmaceuticals in September 2024.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.